재택 진단 기술 혁신과 성장 기회

Transition from Smart Home to Smarter Health At Home Fueling Technology Competition

At-home diagnostics is a rapidly growing field constantly exploring new and innovative solutions to address the challenges of diagnosing broad-spectrum disorders. Recent advancements in emerging at-home diagnostics technologies have attracted significant interest due to their potential to revolutionize the field. This shift has created promising opportunities for technology developers in the at-home diagnostics industry to focus their R&D activities on adopting these technologies for product development. The pandemic has accelerated the adoption of at-home diagnostics technologies, particularly after regulatory authorities granted emergency use authorization for over-the-counter at-home COVID-19 diagnostic tests. As a result, much of the R&D in emerging at-home diagnostics now includes smartphone apps for population-based healthcare data analytics.

The scope of at-home diagnostics technologies is multifaceted, encompassing technical, clinical decision support, privacy, user-friendliness, and economic domains. The primary focus of this study is to identify emerging technologies being adopted across the at-home diagnostics industry that have the potential to surpass conventional technologies. Given the widespread adoption of at-home diagnostics for cardiovascular health, infectious disease detection, and vital signs monitoring, along with the emergence of smartphone apps for data analytics, wearable devices for continuous care, and diagnostic tests that ensure at-home privacy, this study discusses the potential advantages and technology readiness level of these innovations.

Middle-tier medtech companies position themselves as technology developers, while consumer app start-ups focus on analytics, telemetry, and cloud-based services. Together with their top-tier collaborators, this study will highlight key players in this competitive industry that will shape its direction over the next 5 years.

Table of Contents

Strategic Imperatives

• Why Is It Increasingly Difficult to Grow?
• The Strategic Imperative 8
• The Impact of the Top 3 Strategic Imperatives on the At-Home Diagnostics Industry
• Growth Opportunities Fuel the Growth Pipeline Engine
• Research Methodology

Growth Opportunity Analysis

• Scope of Analysis
• Key Evolving Trends Leading to Industry Shifts in At-Home Diagnostics
• Insights from the US Food & Drug Administration FDA Guidelines for At-Home Diagnostics
• Segmentation

Growth Generator

• Growth Drivers
• Growth Restraints

Technology Snapshot

• Tech Overview-Smartphone App
• Companies To Action-Smartphone App
• Tech Assessment-Smartphone App

Technology Snapshot

• Tech Overview-Wearable Devices
• Companies To Action-Wearable Devices
• Tech Assessment-Wearable Devices

Technology Snapshot

• Tech Overview-Diagnostic Tests
• Companies to Action-Diagnostic Tests
• Tech Assessment-Diagnostic Tests
• Future Roadmap

Stakeholder Ecosystem

• Clinical Trials Database Analytics 2023-2025
• Patent Database Analysis of At-Home Diagnostics Innovations 2020-2024
• Federal Funding Analysis 2023-2024
• Private Funding Analysis 2023-2024
• Collaborations & Partnerships 2023-2024
• Industry Trends

Growth Opportunity Universe

• Growth Opportunity 1: Inclusion of Silicon Photonics and Nanotechnology Biosensors for At-Home Diagnostics
• Growth Opportunity 2: At-Home Diagnostics for Cervical Cancer and Tuberculosis
• Growth Opportunity 3: Open-Source Large Language Models LLMs for At-Home Diagnostics

Appendix

• Technology Readiness Levels TRL: Explanation
• Tech Assessment: Explanation

Next Steps

• Benefits and Impacts of Growth Opportunities
• Next Steps
• Legal Disclaimer